New Zealand-based Volpara Solutions will spotlight the VolparaPlatform, a suite of artificial intelligence and software tools that improve breast cancer detection, at the Association for Medical Imaging Management (AHRA) 2020 virtual conference, which takes place from August 11-13.
The VolparaPlatform clinical decision support tools enable radiologists to make informed and timely decisions about a patient’s need for supplemental imaging and/or genetic testing as part of personalized breast care. Volpara®Scorecard+™ software provides three key patient risk insights, including:
- Breast density. VolparaDensity software uses artificial intelligence (AI), physics and imaging data to provide radiologists with an automated, objective, volumetric breast density assessment.
- Short-term risk. Transpara software by ScreenPoint Medical uses AI to automatically assign each screening mammogram a score from 1 to 10. Exams with a high score are more likely to contain breast cancer.
- Lifetime risk. Volpara®Risk™ software captures patient information through a simple, easy-to-use interface. VolparaRisk uses that information, along with the VolparaDensity score, to calculate a woman’s lifetime risk of developing breast cancer using the Tyrer-Cuzick Breast Cancer Risk model (TC8).
“Our vision is to offer each woman a personalized screening regimen for the earliest detection of breast cancer based on her breast density, risk factors and hereditary testing. Using Volpara’s AI-driven, automated breast density to implement a risk-stratified screening program, we have seen tremendous compliance to screening schedules,” reports Leigh Loughran, operations manager medical imaging at Rome Memorial Hospital, Rome, New York.
In addition to Scorecard, VolparaPlatform supports clinics with continuous image quality improvement and workflow productivity tools. These include:
- VolparaLive! software analyzes ideal patient positioning, radiation dose, and compression in real time to provide actionable feedback. If needed, the technologist can use the recommendations to retake the image immediately, to ensure image quality and to reduce call backs.
- VolparaEnterprise software provides a full view of productivity at the technologist, room, department, and enterprise level. This includes tracking the number of studies per day, time of day, and study duration per room. The software also calculates and monitors the dose delivered to patients to ensure that the equipment is performing safely.
Aspen Breast mammography reporting and patient tracking software streamlines workflow by customizing reports and patient letters to include the radiologist’s recommendations based on imaging studies and the results of breast cancer risk models including TC8. Aspen Breast now provides the option of generating medical necessity letters for insurance pre-authorizations for supplemental screening and testing